Literature DB >> 22527450

Presumed melanoma-associated retinopathy (MAR): a presenting sign of primary small intestinal melanoma?

Daniel Rappoport1, Hana Leiba.   

Abstract

Melanoma-associated retinopathy is a paraneoplastic retinopathy associated mostly with cutaneous melanoma. In most cases it presents months to years after diagnosis of primary cutaneous melanoma was made or after recurrence. We describe a 55-year-old male patient who presented with symptoms of decreased vision and photopsia. Diagnosis of melanoma-associated retinopathy was made, but no primary cutaneous melanoma was found. 3 months later he developed intestinal perforation due to small intestinal melanoma.

Entities:  

Mesh:

Year:  2012        PMID: 22527450     DOI: 10.1007/s10792-012-9564-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  19 in total

1.  [Melanoma-associated retinopathy in a patient without a primary tumour].

Authors:  Peder Marcus Diamant; Jan Ulrik Prause; Thomas Rosenberg; Hans Callø Fledelius
Journal:  Ugeskr Laeger       Date:  2004-08-09

2.  Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway.

Authors:  Sharon Shiraga; Grazyna Adamus
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

Review 3.  Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.

Authors:  Nadia Khan; John J Huang; C Stephen Foster
Journal:  Semin Ophthalmol       Date:  2006 Jul-Sep       Impact factor: 1.975

Review 4.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

5.  Blindness caused by photoreceptor degeneration as a remote effect of cancer.

Authors:  R A Sawyer; J B Selhorst; L E Zimmerman; W F Hoyt
Journal:  Am J Ophthalmol       Date:  1976-05       Impact factor: 5.258

6.  Photoreceptor proteins as cancer-retina antigens.

Authors:  Alexandr V Bazhin; Dirk Schadendorf; Nadine Willner; Charles De Smet; Anita Heinzelmann; Natalya K Tikhomirova; Viktor Umansky; Pavel P Philippov; Stefan B Eichmüller
Journal:  Int J Cancer       Date:  2007-03-15       Impact factor: 7.396

7.  Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site.

Authors:  H Kiratli; C E Thirkill; S Bilgiç; B Eldem; A Keçeci
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

8.  Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.

Authors:  C Pföhler; A Haus; A Palmowski; S Ugurel; K W Ruprecht; C E Thirkill; W Tilgen; U Reinhold
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

9.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Authors:  A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

Review 10.  Melanoma of the small intestine.

Authors:  Marko Lens; Veronique Bataille; Zoran Krivokapic
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

View more
  2 in total

1.  Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.

Authors:  Monica D Dalal; Catherine W Morgans; Robert M Duvoisin; Elizabeth A Gamboa; Brett G Jeffrey; Sunir J Garg; Chi-Chao Chan; H Nida Sen
Journal:  Ophthalmology       Date:  2013-09-17       Impact factor: 12.079

2.  Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.

Authors:  Richard E Stead; Maryke A Fox; Emily Staples; Chea S Lim
Journal:  Doc Ophthalmol       Date:  2013-06-22       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.